Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zaniboni

Showing results (141-150 of 233) with videos related to

Pageof 24
Sort By:
Cancers|June 26, 2026
Cancer-Related Cognitive Impairment in Breast Cancer: Current State of Knowledge, Mechanisms, Diagnosis, Prevention and TreatmentFederica Andreis, Chiara Deori, Valentina Giubileo, et al.
The Oncologist|January 8, 2011
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximabMario Scartozzi, Alessandra Mandolesi, Riccardo Giampieri, et al.
Reviews on Recent Clinical Trials|August 1, 2019
Yoga Protocol for Cancer Patients: A Systematic Exploration of Psychophysiological BenefitsMara Mirandola, Miguel David Sabogal Rueda, Federica Andreis, et al.
Palliative & Supportive Care|June 27, 2014
Assessing cancer caregivers' needs for an early targeted psychosocial support project: The experience of the oncology department of the Poliambulanza FoundationFausto Meriggi, Federica Andreis, Veronica Premi, et al.
Reviews on Recent Clinical Trials|April 10, 2018
Impact of a Psycho-Educational Team in early Breast Cancer Patients' Coping Strategies: The Venere ProjectFederica Andreis, Fausto Meriggi, Claudio Codignola, et al.
BMC Cancer|August 29, 2009
Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysisMario Scartozzi, Italo Bearzi, Alessandra Mandolesi, et al.
British Journal of Cancer|June 21, 2017
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximabLaura Demurtas, Marco Puzzoni, Riccardo Giampieri, et al.
JAMA Network Open|March 29, 2021
Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysisFausto Petrelli, Alessio Cortellini, Alice Indini, et al.
International Journal of Cancer|January 26, 2010
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecanMario Scartozzi, Alessandra Mandolesi, Riccardo Giampieri, et al.
The Lancet. Oncology|December 14, 2007
Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trialStefano Cascinu, Rossana Berardi, Roberto Labianca, et al.
Pageof 24

Showing results (141-150 of 233) with videos related to

Sort By:
Pageof 24
Cancers|June 26, 2026
Cancer-Related Cognitive Impairment in Breast Cancer: Current State of Knowledge, Mechanisms, Diagnosis, Prevention and TreatmentFederica Andreis, Chiara Deori, Valentina Giubileo, et al.
The Oncologist|January 8, 2011
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximabMario Scartozzi, Alessandra Mandolesi, Riccardo Giampieri, et al.
Reviews on Recent Clinical Trials|August 1, 2019
Yoga Protocol for Cancer Patients: A Systematic Exploration of Psychophysiological BenefitsMara Mirandola, Miguel David Sabogal Rueda, Federica Andreis, et al.
Palliative & Supportive Care|June 27, 2014
Assessing cancer caregivers' needs for an early targeted psychosocial support project: The experience of the oncology department of the Poliambulanza FoundationFausto Meriggi, Federica Andreis, Veronica Premi, et al.
Reviews on Recent Clinical Trials|April 10, 2018
Impact of a Psycho-Educational Team in early Breast Cancer Patients' Coping Strategies: The Venere ProjectFederica Andreis, Fausto Meriggi, Claudio Codignola, et al.
BMC Cancer|August 29, 2009
Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysisMario Scartozzi, Italo Bearzi, Alessandra Mandolesi, et al.
British Journal of Cancer|June 21, 2017
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximabLaura Demurtas, Marco Puzzoni, Riccardo Giampieri, et al.
JAMA Network Open|March 29, 2021
Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysisFausto Petrelli, Alessio Cortellini, Alice Indini, et al.
International Journal of Cancer|January 26, 2010
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecanMario Scartozzi, Alessandra Mandolesi, Riccardo Giampieri, et al.
The Lancet. Oncology|December 14, 2007
Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trialStefano Cascinu, Rossana Berardi, Roberto Labianca, et al.
Pageof 24